Erika L. Eves
2021
In 2021, Erika L. Eves earned a total compensation of $236.7K as Vice President, Finance & Administration at Navidea Biopharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $29,614 |
|---|---|
| Option Awards | $23,481 |
| Salary | $171,072 |
| Other | $12,563 |
| Total | $236,730 |
Eves received $171.1K in salary, accounting for 72% of the total pay in 2021.
Eves also received $29.6K in non-equity incentive plan, $23.5K in option awards and $12.6K in other compensation.
Rankings
In 2021, Erika L. Eves' compensation ranked 11,861st out of 12,415 executives tracked by ExecPay. In other words, Eves earned more than 4.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,861 out of 12,415 | 5th |
Division Manufacturing | 5,240 out of 5,505 | 5th |
Major group Chemicals And Allied Products | 2,292 out of 2,375 | 4th |
Industry group Drugs | 2,032 out of 2,096 | 3rd |
Industry In Vitro and In Vivo Diagnostic Substances | 58 out of 61 | 5th |
Source: SEC filing on October 24, 2022.
Eves' colleagues
We found four more compensation records of executives who worked with Erika L. Eves at Navidea Biopharmaceuticals in 2021.